Clinical trial
Non-small Cell Lung Cancer Study US75 (Z-PACT)
NCT00086268
Study timeline
Study start (unknown)2004-04-01Date precision: month
Registry last updated2017-09-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Carcinomaunresolved
Interventions
zoledronic acidDRUG · verified · RxNorm: zoledronic acid
TaxotereDRUG
CarboplatinDRUG · verified · RxNorm: carboplatin
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
AtlantaGeorgia, United States2Las VegasNevada, United States2CharlestonSouth Carolina, United States2HonoluluHawaii, United States2SyracuseNew York, United States2Baton RougeLouisiana, United States2TylerTexas, United States2ChicagoIllinois, United States1Los AngelesCalifornia, United States1MiamiFlorida, United States1IndianapolisIndiana, United States1Oklahoma CityOklahoma, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00086268 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.